Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors (Protocol)

Last updated on 23-8-2019 by Anonymous (not verified)

Peer reviewed scientific article



This is the protocol for a review and there is no abstract. The objectives are as follows:To evaluate the immunogenicity, clinical efficacy, and safety of prophylactic HPV vaccines in females. The assessment of clinical efficacy will address protection against HPV infection (for homologous and heterologous HPV types), against re-infection, against cervical cancer and its precursors (high-grade CIN (grade 2 or grade 3), adenocarcinoma in situ) in women previously not exposed to HPV infection (negative at enrolment for both HPV DNA and antibodies against the vaccine HPV types). We will assess…

Associated health topics:

QR code

QR code for this page URL